Marie Menard

Company: Revolution Medicines

Job title: Senior Scientist I - Cancer Immunology

Seminars:

Enhancing the Therapeutic Potential of RAS-Targeted Inhibitors Through Preclinical Tumor Models 1:15 pm

Discussing the importance of tumor models in unraveling the complexities of RAS signaling, tumor heterogeneity, and resistance mechanisms to optimize the design and application of RAS-targeted therapies Navigating through challenges such as accurate representation of RAS biology, predicting potential off-target effects, and assessing therapeutic responses in preclinical studies Discussing innovative approaches such as genetically engineered…Read more

day: Conference Day One - Track 2 - Post Lunch